Author:
Zhu Kai,Drew Yvette,Jayakumar Saumya
Reference13 articles.
1. Case definition and phenotype standardization in drug-induced liver injury;Aithal;Clin. Pharmacol. Ther. [Internet].,2011
2. Olaparib-induced immune-mediated liver injury;Alshelleh;ACG Case Rep. J. [Internet].,2022
3. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period;Andrade;Gastroenterology [internet].,2005
4. Bruin, M.A.C., Sonke, G.S., Beijnen, J.H., Huitema, A.D.R., 2022. Pharmacokinetics and pharmacodynamics of PARP inhibitors in oncology. Clin. Pharmacokinet. 2022 6112 [Internet]. 2022 Oct 11 [cited 2024 Mar 6];61(12):1649–75. .
5. Overall survival with maintenance Olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: the SOLO1/GOG 3004 Trial;Disilvestro;J Clin Oncol [internet],2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Olaparib;Reactions Weekly;2024-07-20